TCT-296 Assessment the performance value of CRUSADE and MEHRAN bleeding risk scores with the observed bleeding events among ACS Tunisian patients.

Abstract

Listen

Translate article

P O S T E R S separated into access site used, and procedural and clinical outcomes were compared. MACE was reported at 30 days. Results: 685 patients underwent RA PCI (Radial n 1⁄4 398 and Femoral n 1⁄4 287) during the study period. There was a predominance of male patients in the radial group (75.4% Vs 63.4% p<0.001) and more likely to have left ventricular impairment (32.8% Vs 15.4%, p<0.001). No other difference in baseline demographics was seen between the two groups. Procedural success was identical in both cohorts (98.5 Vs 97.5, p1⁄40.62) but radial cohort received more drug-eluting stents (91.2% Vs 85.3%, p1⁄40.03). Guide catheter size in the radial cohort was smaller (6.55F Vs 6.95F, p<0.001), average burr size was similar. The femoral group underwent more left main-stem PCI (14.2% Vs 21.8%, p1⁄40.01) and additional imaging (23.2% Vs 32.9%, p1⁄40.03). The procedural time (76.3 vs 92.6mins, p<0.001) and time to first balloon inflation (39 vs 54mins, p<0.001) were significantly lower in the radial cohort, as was mean length of stay (1.43 vs 2.93 days, p1⁄40.008). Bleeding and vascular access complications were similar between the two groups as was 30 day MACE (Radial 6.45% vs Femoral 4.08%, p1⁄40.15). Conclusions: This is the largest comparison to date of radial versus femoral access rotablation. Our data demonstrate that radial RA PCI can be performed safely, with smaller guide catheters and similar procedural success. Procedural time and time to first balloon inflation was significantly less in the radial cohort, whereas 30-day MACE rates and access-associated complications were similar between both groups. Our results show that radial access is safe, effective and perhaps more efficient method for performing RA.